Assessment of the external validity of the AJCC 8
American Joint Committee on Cancer (AJCC)
Prognosis
Surveillance, Epidemiology and End Results (SEER)
small intestinal adenocarcinoma
staging
Journal
Journal of gastrointestinal oncology
ISSN: 2078-6891
Titre abrégé: J Gastrointest Oncol
Pays: China
ID NLM: 101557751
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
entrez:
12
6
2019
pubmed:
12
6
2019
medline:
12
6
2019
Statut:
ppublish
Résumé
The current study evaluates the validity and performance of the 8 Surveillance, Epidemiology and End Results (SEER) database [2004-2015] was explored and AJCC 6 A total of 2,997 small intestinal adenocarcinoma patients were eligible and included in the analysis. Overall survival was compared according to the three AJCC staging systems. For the three versions, the P value for the trend in overall survival was significant (P<0.0001). Cancer-specific Cox regression hazard was calculated for the three staging systems. Pairwise hazard ratio comparisons between different AJCC 6 There is no evidence that AJCC 8
Sections du résumé
BACKGROUND
BACKGROUND
The current study evaluates the validity and performance of the 8
METHODS
METHODS
Surveillance, Epidemiology and End Results (SEER) database [2004-2015] was explored and AJCC 6
RESULTS
RESULTS
A total of 2,997 small intestinal adenocarcinoma patients were eligible and included in the analysis. Overall survival was compared according to the three AJCC staging systems. For the three versions, the P value for the trend in overall survival was significant (P<0.0001). Cancer-specific Cox regression hazard was calculated for the three staging systems. Pairwise hazard ratio comparisons between different AJCC 6
CONCLUSIONS
CONCLUSIONS
There is no evidence that AJCC 8
Identifiants
pubmed: 31183191
doi: 10.21037/jgo.2019.01.15
pii: jgo-10-03-421
pmc: PMC6534713
doi:
Types de publication
Journal Article
Langues
eng
Pagination
421-428Déclaration de conflit d'intérêts
Conflicts of Interest: The authors have no conflicts of interest to declare.
Références
Saudi J Gastroenterol. 2009 Oct-Dec;15(4):264-7
pubmed: 19794274
Dig Liver Dis. 2014 Feb;46(2):97-104
pubmed: 23796552
J Clin Epidemiol. 2015 Jan;68(1):25-34
pubmed: 25441703
Surgery. 2015 Aug;158(2):486-93
pubmed: 26013988
Osteoarthritis Cartilage. 2016 May;24(5):763-4
pubmed: 26802548
Mod Pathol. 2016 Apr;29(4):402-15
pubmed: 26892442
World J Gastrointest Oncol. 2016 Jun 15;8(6):509-19
pubmed: 27326320
Gastroenterol Clin North Am. 2016 Sep;45(3):447-57
pubmed: 27546842
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
Expert Rev Gastroenterol Hepatol. 2017 Jul;11(7):695-701
pubmed: 28276812
World J Gastroenterol. 2017 Mar 14;23(10):1872-1880
pubmed: 28348494
JAMA Oncol. 2017 Nov 1;3(11):1546-1553
pubmed: 28617917
J Dermatolog Treat. 2018 Mar;29(2):176-181
pubmed: 28745581
Future Oncol. 2017 Aug 24;:null
pubmed: 28836445
J Surg Oncol. 2018 Mar;117(3):397-408
pubmed: 29044591
Clin Transl Oncol. 2018 Jun;20(6):794-800
pubmed: 29086248
Breast Cancer Res Treat. 2018 Feb;168(1):269-275
pubmed: 29143220
Ther Adv Urol. 2017 Nov 08;10(2):35-42
pubmed: 29434671
PLoS Genet. 2018 Mar 9;14(3):e1007200
pubmed: 29522538
Medicine (Baltimore). 2018 Mar;97(13):e0185
pubmed: 29595652